Search

Background Mucosal healing (MH) is associated with improved clinical outcomes in patients with Crohn's disease (CD) and ulcerative colitis (UC). MH as a target for treatment has been suggested, although there is little pediatric data. The goal of this study was to evaluate MH in clinical practice in pediatric patients with inflammatory bowel disease in clinical remission. Methods A retrospective review of electronic health record data was performed on all patients with CD or UC who underwent at least 2 colonoscopies from 2010 through 2016. Only patients in clinical remission undergoing a scope for MH were included in our study. The incidence of MH and histologic healing (HH) was analyzed, along with cumulative rates of MH in each group. MH was defined by both physician assessment of MH and an endoscopic score of zero for CD and UC. Results A total of 76 patients with CD and 28 patients with UC underwent at least one MH scope while in clinical remission. Of the 76 patients with CD, 51 patients (67%) demonstrated MH by physician assessment, 34 patients (45%) demonstrated MH by a simple endoscopic score for CD of zero, and 35 patients (46%) demonstrated HH. Of the 28 patients with UC, 20 patients (71%) demonstrated MH by physician assessment, 10 patients (36%) demonstrated MH by a Mayo score of zero, and 10 patients (36%) demonstrated HH. Nineteen patients underwent a second MH scope and 11 (58%) demonstrated MH by physician assessment, 7 patients (37%) demonstrated MH by simple endoscopic score for CD or Mayo scores of zero, and 5 patients (26%) demonstrated HH. Of those patients with active disease, 21 of 25 patients with CD underwent escalation of therapy, whereas 8 of 8 patients with UC underwent escalation of therapy. Cumulative rates of MH when defined by physician assessment were 79% (60 of 76 patients) in CD and 79% (22 of 28 patients) in UC. Conclusions MH is feasible in pediatric CD and UC, and rates of cumulative MH in pediatric patients are similar to previously published adult data. In children with inflammatory bowel disease in clinical remission, approximately one-third demonstrate active disease at endoscopy.

The structure and vitamin E (tocopherol and tocotrienol), fatty acid and phytosterol content and composition of seeds of Brassica fruticulosa Cyr. (Brassicaceae) were characterized. Seed size and elevated content of γ-tocotrienol, and γ- tocopherol and low of α- tocopherol can be useful for distinguishing seeds of B. fruticolosa from those of Sicilian Brassica sect. Brassica. The concentration of the tocotrienol is about one third of the vitamin E content. This profile makes this wild species worth to be recovered as food source and its germplasm preserved in a gene bank.

Bluetongue (BT) is an infectious, non-contagious, arthropod-borne disease transmitted by biting midges. When BT spread throughout the Balkans (affecting Albania, Bosnia-Herzegovina, Bulgaria, Croatia, the Former Yugoslav Republic of Macedonia and Serbia and Montenegro), it caused serious concerns for veterinary authorities in all countries in the eastern Mediterranean. In 2003-2004 a web-based BT geographic information system network was developed and implemented to provide veterinary services with a tool to manage and analyse data on the disease and to exchange information. The system was centralised to ensure there was a common epidemiological surveillance strategy. Spatial and alphanumerical data on the disease were organised in a single relational geographic database. The system was equipped with a number of applications for the display of dynamic maps and data information via the web, with multi-user access for simultaneous queries from additional users.